Infections in Older Patients:
Antimicrobial Resistance and C. difficile Colitis
Wednesday, February 27, 2019
4:00 pm ET, 3:00 pm CT, 2:00 pm MT, 1:00 pm PT
Registration deadline February 20, 2019
As we age, comes an increased risk for infections. The decline in antibacterial development
combined with the increase of multi-drug resistant organisms (MOROS) challenges care managers to learn how to advocate for their aging clients and what key issues they need to be aware of. This webinar will educate Aging Life Care Managers® on common risk factors, drug resistant pathogens, treatment strategies, and prevention methods.
Webinar Goal: Aging Life Care Managers will be able to better advocate for their older adults suffering from infections.
Participants will be able to:
- Describe some of the reasons for increased infection risk in the elderly and identify some of the most common infections in the elderly.
- Describe the contributions of ca.re settings to increased infection rates & antimicrobial resistance and identify the most prevalent types found in older adults.
- Review prevention & treatment and discuss treatment modalities.
About the Presenter:
Dr. Wack received his Medical Degree from the Medical College of Ohio. He completed his residency in internal medicine at Indiana University Medical Center and fellowship in Infectious Diseases from the University of Iowa Hospitals and Clinics. He has practiced Infectious Disease medicine and participated in research in both academic and private practice settings. He served as Co-chair of Infectious Disease at IU Health for 10 years, education director for Infectious Diseases at Methodist Hospital of IU Health, and Pharmacy and Therapeutics advisor at Methodist Hospital. He has also been active in developing hospital-based antimicrobial management programs in both private and academic practice settings. He has lectured both nationally and internationally on the topics of antimicrobial use and resistance. Or. Wack has collaborated for over 20 years in developing programs to combat antimicrobial resistance in hospital settings. This has led to the training of 20 infectious disease pharmacists, multiple scientific publications, and cost savings for their member institutions that exceed $30 million.